Skip to main content
. 2003 Nov 11;89(10):1979–1986. doi: 10.1038/sj.bjc.6601361

Figure 3.

Figure 3

Clonogenic survival for HaCaT and HaCaT-ras cells treated with cisplatin (μg ml−1) for 1 h. Cells were plated in medium containing 1 nM l-deprenyl and exposed to cisplatin 16 h later. Absolute control plating efficiencies were 23.6±1.3 for HaCaT cells and 52.2±2.1 for HaCaT-ras cells.